Stay updated on Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.

Latest updates to the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor update to the page’s version history.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0, indicating a site version update. This metadata change does not alter the study details or how users interact with the page.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now indicates the study is not recruiting participants, clarifying its current status. It also adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag (v3.6.0).SummaryDifference0.5%

- Check41 days agoChange DetectedThe page footer now shows Revision: v3.5.5 instead of v3.5.4. This indicates a small version update to the site's template or code.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page. This indicates a minor internal update to the entry without altering study details or displayed information.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history for this study record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.